The 29th Annual Meeting of the Japanese Society for Vaccinology/The 66th Annual Meeting of the Japanese Society of Clinical Virology

*Takafumi Noguchi^1,2, Hidehiko Suzuki^1,2, Mayuko Yamawaki², Takeshi Sugimoto^1,2, Yuka Koizumi², Kazue Utsumi², Paola Miyazato^1,2, Eiji Morita³, Hirotaka Ebina^1,2 (1. Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 2. THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY, 3. Department of Biochemistry and Molecular Biology, Faculty of Agriculture and Life Science, Hirosaki University)

*Reno Otsuka¹, Hiroshi Ishii², Kenta Jounai¹, Chang Tang¹, Midori Okazaki², Midori Nakamura², Tetsuro Matano³ (1. Institute of Health Science, Kirin Holdings Co., Ltd., 2. Departmemt of Latent Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, 3. National Institute of Infectious Diseases, Japan Institute for Health Security)

*Mayuko Yamawaki¹, Yuka Koizumi¹, Hiroki Nakayama¹, Takafumi Noguchi¹, Rie Doi¹, Kazue Utsumi¹, Masakatsu Tsuji¹, Shiro Takekawa¹ (1. The Research Foundation for Microbial Diseases of Osaka University)

*Mayu Kumamoto¹, Takuto Nogimori², Ayae Nishiyama², Yuji Masuta², Shokichi Takahama², Nabila Seddiki³, Takuya Yamamoto² (1. Osaka Univ., 2. National Institutes of Biomedical Innovation, Health and Nutrition, 3. Paris-Saclay Univ.)

*Toshiro Hirai^1,2,3,4, Soichiro Hashimoto^2,3, Kazuo Takayama⁵, Yasuo Yoshioka^1,2,3,4,6 (1. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 2. Vaccine Creation Group, Research Institute for Microbial Diseases, The University of Osaka, 3. Laboratory of Nano-design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, The University of Osaka, 4. Center for Advanced Modalities and DDS, The University of Osaka, 5. Center for iPS Cell Research and Application, Kyoto University, 6. The Research Foundation for Microbial Diseases of Osaka University)

*Haruki Hirata^1,2, Toshiro Hirai^1,2,3,4, Yasuo Yoshioka^1,2,3,4,5 (1. Graduate School of Pharmaceutical Sciences, The University of Osaka, 2. Research Institute for Microbial Diseases, The University of Osaka, 3. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 4. Center for Advanced Modalities and DDS, The University of Osaka, 5. The Research Foundation for Microbial Diseases of Osaka University)